Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children.

Fritz CQ, Edwards KM, Self WH, Grijalva CG, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Wunderink RG, Anderson EJ, Bramley AM, Jain S, Williams DJ.

Pediatrics. 2019 Jul;144(1). pii: e20183090. doi: 10.1542/peds.2018-3090.

PMID:
31217309
2.

The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE).

Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler V, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 Jun 3. pii: ciz460. doi: 10.1093/cid/ciz460. [Epub ahead of print]

PMID:
31157370
3.

Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing.

Qi C, Hountras P, Pickens CO, Walter JM, Kruser JM, Singer BD, Seed P, Green SJ, Wunderink RG.

J Med Microbiol. 2019 Jul;68(7):996-1002. doi: 10.1099/jmm.0.000968. Epub 2019 May 28.

PMID:
31136295
4.

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.

Isturiz RE, Ramirez J, Self WH, Grijalva CG, Counselman FL, Volturo G, Ostrosky-Zeichner L, Peyrani P, Wunderink RG, Sherwin R, Overcash JS, Oliva SP, File T, Wiemken TL, McLaughlin JM, Pride MW, Gray S, Alexander R, Ford KD, Jiang Q, Jodar L.

Vaccine. 2019 May 31;37(25):3352-3361. doi: 10.1016/j.vaccine.2019.04.087. Epub 2019 May 6.

5.

Patient and Family Engagement During Treatment Decisions in an ICU: A Discourse Analysis of the Electronic Health Record.

Kruser JM, Benjamin BT, Gordon EJ, Michelson KN, Wunderink RG, Holl JL, Schwarze ML.

Crit Care Med. 2019 Jun;47(6):784-791. doi: 10.1097/CCM.0000000000003711.

PMID:
30896465
6.

Procalcitonin as a Biomarker in Rhinosinusitis: A Systematic Review.

Dilger AE, Peters AT, Wunderink RG, Tan BK, Kern RC, Conley DB, Welch KC, Holl JL, Smith SS.

Am J Rhinol Allergy. 2019 Mar;33(2):103-112. doi: 10.1177/1945892418810293. Epub 2018 Dec 3.

7.

Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.

Paonessa JR, Shah RD, Pickens CI, Lizza BD, Donnelly HK, Malczynski M, Qi C, Wunderink RG.

Chest. 2019 May;155(5):999-1007. doi: 10.1016/j.chest.2019.02.007. Epub 2019 Feb 15.

PMID:
30776365
8.

Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials.

Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF.

Clin Infect Dis. 2019 Feb 4. doi: 10.1093/cid/ciz093. [Epub ahead of print]

PMID:
30722013
9.
10.

Challenges in severe community-acquired pneumonia: a point-of-view review.

Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG.

Intensive Care Med. 2019 Feb;45(2):159-171. doi: 10.1007/s00134-019-05519-y. Epub 2019 Jan 31. Review.

PMID:
30706119
11.

Principles and Practice of Antibiotic Stewardship in the ICU.

Pickens CI, Wunderink RG.

Chest. 2019 Jul;156(1):163-171. doi: 10.1016/j.chest.2019.01.013. Epub 2019 Jan 25. Review.

PMID:
30689983
12.

Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.

Self WH, Wunderink RG, DiNubile MJ, Stossel TP, Levinson SL, Williams DJ, Anderson EJ, Bramley AM, Jain S, Edwards KM, Grijalva CG.

Clin Infect Dis. 2018 Dec 17. doi: 10.1093/cid/ciy1049. [Epub ahead of print]

PMID:
30561561
13.

Serological response to influenza vaccination among adults hospitalized with community-acquired pneumonia.

Pratt CQ, Zhu Y, Grijalva CG, Wunderink RG, Mark Courtney D, Waterer G, Levine MZ, Jefferson S, Self WH, Williams DJ, Finelli L, Bramley AM, Edwards KM, Jain S, Anderson EJ.

Influenza Other Respir Viruses. 2019 Mar;13(2):208-212. doi: 10.1111/irv.12622. Epub 2018 Dec 17.

14.

A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis.

Rello J, Kalwaje Eshwara V, Lagunes L, Alves J, Wunderink RG, Conway-Morris A, Rojas JN, Alp E, Zhang Z.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):319-323. doi: 10.1007/s10096-018-3428-y. Epub 2018 Nov 13.

PMID:
30426331
15.

Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia.

Walter JM, Ren Z, Yacoub T, Reyfman PA, Shah RD, Abdala-Valencia H, Nam K, Morgan VK, Anekalla KR, Joshi N, McQuattie-Pimentel AC, Chen CI, Chi M, Han S, Gonzalez-Gonzalez FJ, Soberanes S, Aillon RP, Watanabe S, Williams KJN, Lu Z, Paonessa J, Hountras P, Breganio M, Borkowski N, Donnelly HK, Allen JP, Amaral LA, Bharat A, Misharin AV, Bagheri N, Hauser AR, Budinger GRS, Wunderink RG.

Am J Respir Crit Care Med. 2019 May 15;199(10):1225-1237. doi: 10.1164/rccm.201804-0650OC.

PMID:
30398927
16.

Guidelines to Manage Community-Acquired Pneumonia.

Wunderink RG.

Clin Chest Med. 2018 Dec;39(4):723-731. doi: 10.1016/j.ccm.2018.07.006. Review.

PMID:
30390744
17.

Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.

Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, Mathers AJ, Bassetti M, Vazquez J, Cornely OA, Solomkin J, Bhowmick T, Bishara J, Daikos GL, Felton T, Furst MJL, Kwak EJ, Menichetti F, Oren I, Alexander EL, Griffith D, Lomovskaya O, Loutit J, Zhang S, Dudley MN, Kaye KS.

Infect Dis Ther. 2018 Dec;7(4):439-455. doi: 10.1007/s40121-018-0214-1. Epub 2018 Oct 1.

18.

Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.

Bellew S, Grijalva CG, Williams DJ, Anderson EJ, Wunderink RG, Zhu Y, Waterer GW, Bramley AM, Jain S, Edwards KM, Self WH.

Clin Infect Dis. 2019 May 30;68(12):2026-2033. doi: 10.1093/cid/ciy826.

PMID:
30265290
19.

Multidimensional assessment of alveolar T cells in critically ill patients.

Walter JM, Helmin KA, Abdala-Valencia H, Wunderink RG, Singer BD.

JCI Insight. 2018 Sep 6;3(17). pii: 123287. doi: 10.1172/jci.insight.123287. eCollection 2018 Sep 6.

20.

Extracorporeal Membrane Oxygenation Can Successfully Support Patients With Severe Acute Respiratory Distress Syndrome in Lieu of Mechanical Ventilation.

Kurihara C, Walter JM, Singer BD, Cajigas H, Shayan S, Al-Qamari A, DeCamp MM, Wunderink R, Budinger GRS, Bharat A.

Crit Care Med. 2018 Nov;46(11):e1070-e1073. doi: 10.1097/CCM.0000000000003354.

PMID:
30095500
21.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, François Timsit J, Welte T, Wunderink R.

ERJ Open Res. 2018 Jun 26;4(2). pii: 00028-2018. doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

22.

Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia.

Bozio CH, Flanders WD, Finelli L, Bramley AM, Reed C, Gandhi NR, Vidal JE, Erdman D, Levine MZ, Lindstrom S, Ampofo K, Arnold SR, Self WH, Williams DJ, Grijalva CG, Anderson EJ, McCullers JA, Edwards KM, Pavia AT, Wunderink RG, Jain S.

Open Forum Infect Dis. 2018 Mar 16;5(4):ofy061. doi: 10.1093/ofid/ofy061. eCollection 2018 Apr.

23.

Testing for Respiratory Viruses in Adults With Severe Lower Respiratory Infection.

Walter JM, Wunderink RG.

Chest. 2018 Nov;154(5):1213-1222. doi: 10.1016/j.chest.2018.06.003. Epub 2018 Jun 14. Review.

PMID:
29908153
24.

A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.

Gessner BD, Jiang Q, Van Werkhoven CH, Sings HL, Webber C, Scott D, Neuzil KM, O'Brien KL, Wunderink RG, Grobbee DE, Bonten MJM, Jodar L.

Vaccine. 2018 May 31. pii: S0264-410X(18)30763-1. doi: 10.1016/j.vaccine.2018.05.097. [Epub ahead of print]

25.

In-Hospital Deaths Among Adults With Community-Acquired Pneumonia.

Waterer GW, Self WH, Courtney DM, Grijalva CG, Balk RA, Girard TD, Fakhran SS, Trabue C, McNabb P, Anderson EJ, Williams DJ, Bramley AM, Jain S, Edwards KM, Wunderink RG.

Chest. 2018 Sep;154(3):628-635. doi: 10.1016/j.chest.2018.05.021. Epub 2018 May 30.

PMID:
29859184
26.

Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e00198-18. doi: 10.1128/AAC.00198-18. Print 2018 Apr. No abstract available.

27.

Future Research Directions in Pneumonia. NHLBI Working Group Report.

Dela Cruz CS, Wunderink RG, Christiani DC, Cormier SA, Crothers K, Doerschuk CM, Evans SE, Goldstein DR, Khatri P, Kobzik L, Kolls JK, Levy BD, Metersky ML, Niederman MS, Nusrat R, Orihuela CJ, Peyrani P, Prince AS, Ramírez JA, Ridge KM, Sethi S, Suratt BT, Sznajder JI, Tsalik EL, Walkey AJ, Yende S, Aggarwal NR, Caler EV, Mizgerd JP.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):256-263. doi: 10.1164/rccm.201801-0139WS.

28.

Response.

Self WH, Upchurch CP, Wunderink RG, Waterer GW, Grijalva CG, Edwards KM.

Chest. 2018 Mar;153(3):763-764. doi: 10.1016/j.chest.2017.09.020. No abstract available.

PMID:
29519302
29.

Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia.

Rhodes NJ, Cruce CE, O'Donnell JN, Wunderink RG, Hauser AR.

Curr Infect Dis Rep. 2018 Mar 6;20(2):3. doi: 10.1007/s11908-018-0609-x. Review.

30.

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.

Self WH, Wunderink RG, Jain S, Edwards KM, Grijalva CG; Etiology of Pneumonia in the Community (EPIC) Study Investigators.

Clin Infect Dis. 2018 May 2;66(10):1640-1641. doi: 10.1093/cid/cix1090. No abstract available.

PMID:
29360954
31.

Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays.

Wunderink RG, Self WH, Anderson EJ, Balk R, Fakhran S, Courtney DM, Qi C, Williams DJ, Zhu Y, Whitney CG, Moore MR, Bramley A, Jain S, Edwards KM, Grijalva CG.

Clin Infect Dis. 2018 May 2;66(10):1504-1510. doi: 10.1093/cid/cix1066. Erratum in: Clin Infect Dis. 2018 Sep 28;67(8):1313.

32.

Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia.

Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, Self WH, Anderson EJ, Wunderink RG, Edwards KM, Pavia AT, Jain S, McCullers JA.

J Infect Dis. 2018 Jun 20;218(2):179-188. doi: 10.1093/infdis/jix641.

PMID:
29228381
33.

MERS, SARS and other coronaviruses as causes of pneumonia.

Yin Y, Wunderink RG.

Respirology. 2018 Feb;23(2):130-137. doi: 10.1111/resp.13196. Epub 2017 Oct 20. Review.

34.

Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01323-17. doi: 10.1128/AAC.01323-17. Print 2018 Jan. Erratum in: Antimicrob Agents Chemother. 2018 Mar 27;62(4):.

35.

Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia.

Lu X, Schneider E, Jain S, Bramley AM, Hymas W, Stockmann C, Ampofo K, Arnold SR, Williams DJ, Self WH, Patel A, Chappell JD, Grijalva CG, Anderson EJ, Wunderink RG, McCullers JA, Edwards KM, Pavia AT, Erdman DD.

J Infect Dis. 2017 Nov 27;216(9):1104-1111. doi: 10.1093/infdis/jix455.

37.

Impact of Multiple Daily Clinical Pharmacist-Enforced Assessments on Time in Target Sedation Range.

Lizza BD, Jagow B, Hensler D, Cooper CJ, Short EJ, Maas MB, Naidech AM, Wunderink RG.

J Pharm Pract. 2018 Oct;31(5):445-449. doi: 10.1177/0897190017729522. Epub 2017 Sep 6.

PMID:
28874082
38.

Intensive Care Unit Outcomes Among Patients With Cancer After Palliative Radiation Therapy.

Kruser JM, Rakhra SS, Sacotte RM, Wehbe FH, Rademaker AW, Wunderink RG, Kruser TJ.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):854-858. doi: 10.1016/j.ijrobp.2017.06.2463. Epub 2017 Jun 28.

39.

Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.

Limaye AP, Stapleton RD, Peng L, Gunn SR, Kimball LE, Hyzy R, Exline MC, Files DC, Morris PE, Frankel SK, Mikkelsen ME, Hite D, Enfield KB, Steingrub J, O'Brien J, Parsons PE, Cuschieri J, Wunderink RG, Hotchkin DL, Chen YQ, Rubenfeld GD, Boeckh M.

JAMA. 2017 Aug 22;318(8):731-740. doi: 10.1001/jama.2017.10569.

40.

Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes.

Upchurch CP, Grijalva CG, Wunderink RG, Williams DJ, Waterer GW, Anderson EJ, Zhu Y, Hart EM, Carroll F, Bramley AM, Jain S, Edwards KM, Self WH.

Chest. 2018 Mar;153(3):601-610. doi: 10.1016/j.chest.2017.07.035. Epub 2017 Aug 9.

41.

A Critical Care Clinician Survey Comparing Attitudes and Perceived Barriers to Low Tidal Volume Ventilation with Actual Practice.

Weiss CH, Baker DW, Tulas K, Weiner S, Bechel M, Rademaker A, Fought A, Wunderink RG, Persell SD.

Ann Am Thorac Soc. 2017 Nov;14(11):1682-1689. doi: 10.1513/AnnalsATS.201612-973OC.

42.

Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community Study.

Tomczyk S, Jain S, Bramley AM, Self WH, Anderson EJ, Trabue C, Courtney DM, Grijalva CG, Waterer GW, Edwards KM, Wunderink RG, Hicks LA.

Open Forum Infect Dis. 2017 Jun 20;4(2):ofx088. doi: 10.1093/ofid/ofx088. eCollection 2017 Spring.

43.

Advances in the causes and management of community acquired pneumonia in adults.

Wunderink RG, Waterer G.

BMJ. 2017 Jul 10;358:j2471. doi: 10.1136/bmj.j2471. Review.

PMID:
28694251
44.

Severe Respiratory Viral Infections: New Evidence and Changing Paradigms.

Walter JM, Wunderink RG.

Infect Dis Clin North Am. 2017 Sep;31(3):455-474. doi: 10.1016/j.idc.2017.05.004. Epub 2017 Jul 5. Review.

PMID:
28687214
45.

High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis.

Mangat M, Amalakuhan B, Habib S, Reyes LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer GW, Martin-Loeches I, Blanquer J, Sanz F, Marcos PJ, Solé-Violán J, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orihuela CJ, Restrepo MI.

Eur Respir J. 2017 Jul 5;50(1). pii: 1700013. doi: 10.1183/13993003.00013-2017. Print 2017 Jul. No abstract available.

46.

Association between timing of intubation and outcome in critically ill patients: A secondary analysis of the ICON audit.

Bauer PR, Gajic O, Nanchal R, Kashyap R, Martin-Loeches I, Sakr Y, Jakob SM, François B, Wittebole X, Wunderink RG, Vincent JL; ICON Investigators (Supplemental Appendix 1).

J Crit Care. 2017 Dec;42:1-5. doi: 10.1016/j.jcrc.2017.06.010. Epub 2017 Jun 16.

PMID:
28641231
47.

Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials.

Alexander EL, Loutit J, Tumbarello M, Wunderink R, Felton T, Daikos G, Fusaro K, White D, Zhang S, Dudley MN.

Open Forum Infect Dis. 2017 Jun 1;4(2):ofx063. doi: 10.1093/ofid/ofx063. eCollection 2017 Spring.

48.

Angiotensin II for the Treatment of Vasodilatory Shock.

Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM; ATHOS-3 Investigators.

N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21.

49.

Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia.

Bramley AM, Reed C, Finelli L, Self WH, Ampofo K, Arnold SR, Williams DJ, Grijalva CG, Anderson EJ, Stockmann C, Trabue C, Fakhran S, Balk R, McCullers JA, Pavia AT, Edwards KM, Wunderink RG, Jain S; Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) Study Team.

J Infect Dis. 2017 Jun 15;215(12):1873-1882. doi: 10.1093/infdis/jix241.

50.

Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia.

Harris AM, Bramley AM, Jain S, Arnold SR, Ampofo K, Self WH, Williams DJ, Anderson EJ, Grijalva CG, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Winchell JM, Hicks LA.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofx014. doi: 10.1093/ofid/ofx014. eCollection 2017 Winter.

Supplemental Content

Loading ...
Support Center